home / stock / clvrw / clvrw news


CLVRW News and Press, Clever Leaves Holdings Inc. Warrant From 03/30/23

Stock Information

Company Name: Clever Leaves Holdings Inc. Warrant
Stock Symbol: CLVRW
Market: NASDAQ

Menu

CLVRW CLVRW Quote CLVRW Short CLVRW News CLVRW Articles CLVRW Message Board
Get CLVRW Alerts

News, Short Squeeze, Breakout and More Instantly...

CLVRW - Clever Leaves Reports Fourth Quarter and Full Year 2022 Results

- Fourth Quarter and Full Year 2022 Cannabinoid Revenue Increased 71% and 90%, Respectively; Total Annual Revenue Growth was 16% Year-over-Year - - Steady Cost Reductions and Portugal Wind-Down Expected to Drive Production, Cost, and CapEx Efficiencies - - Announces Financial Ou...

CLVRW - Clever Leaves Reschedules Fourth Quarter and Full Year 2022 Conference Call to Thursday, March 30, 2023 at 5:00 p.m. ET

TOCANCIPÁ, Colombia, March 17, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced that it will be res...

CLVRW - Clever Leaves to Hold Fourth Quarter and Full Year 2022 Conference Call on Thursday, March 23, 2023 at 5:00 p.m. ET

TOCANCIPÁ, Colombia, March 09, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call o...

CLVRW - Clever Leaves Announces Wind-Down of Portugal Operations as Part of Ongoing Restructuring Initiatives

Company to Concentrate All Cannabinoid Cultivation and Production Operations in Colombia to Leverage Existing Operational Efficiencies Operational Transition Expected to Generate Approximately $7 Million in Cost Savings by Year-End 2023 TOCANCIPÁ, Colombia, Jan. 23, 2023 (GLO...

CLVRW - Clever Leaves Holdings Inc. (CLVR) Q3 2022 Earnings Call Transcript

Clever Leaves Holdings Inc. (CLVR) Q3 2022 Earnings Conference Call November 9, 2022, 5:00 PM ET Company Participants Jackie Keshner - Investor Relations Andrés Fajardo - Chief Executive Officer Hank Hague - Chief Financial Officer Conference Call Part...

CLVRW - Clever Leaves Reports Third Quarter 2022 Results

Q3 Cannabinoid Revenue Increases 12% Year-Over-Year, with 100% Growth in the Segment Year-to-Date Significant Continued Progress on Cost Reduction Initiatives Driving Sequential Improvements in Adjusted EBITDA Continued Financial Discipline, Operational Improvements, Com...

CLVRW - Portuguese Health Authority Grants Clever Leaves EU-GMP Certification for Post-Harvest Cannabis Flower

TOCANCIPÁ, Colombia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that its facility in Portugal has been granted EU-GMP certification by ...

CLVRW - Clever Leaves Partners with Anden Naturals to Bring Pharmaceutical-Grade Cannabis to Patients in Peru

Peruvian operator Anden Naturals has obtained sanitary registration from the Peruvian Health Authority for its THC dominant products Clever Leaves will cultivate, manufacture, and pack Anden Naturals’ finished products in its EUGMP certified facilities in Colombia T...

CLVRW - Clever Leaves to Hold Third Quarter 2022 Conference Call on Wednesday, November 9, 2022 at 5:00 p.m. ET

TOCANCIPÁ, Colombia, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference c...

CLVRW - Clever Leaves Partners With House of Kush for International Expansion

TOCANCIPÁ, Colombia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced a partnership today with U.S. cannabis-branded genetic innovation company, H...

Previous 10 Next 10